upgradeNERVfinnhub
Minerva Neurosciences, Inc. (NERV) Upgraded to Buy at Jefferies
Jefferies analysts upgraded Minerva Neurosciences, Inc. (NASDAQ:NERV) from Hold to Buy on August 14, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Jefferies analysts upgraded Minerva Neurosciences, Inc. (NASDAQ:NERV) from Hold to Buy on August 14, 2026.
Read moreMaxim Group reiterated its Buy rating on NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) on August 14, 2026.
Read moreLadenburg Thalmann reiterated its Buy rating on Creative Realities, Inc. (NASDAQ:CREX) on August 14, 2026.
Read moreCantor Fitzgerald reiterated its Neutral rating on SoundThinking, Inc. (NASDAQ:SSTI) on August 14, 2026.
Read moreCitizens analysts downgraded SoundThinking, Inc. (NASDAQ:SSTI) from Market Outperform to Market Perform on August 14, 2026.
Read moreLake Street analysts downgraded SoundThinking, Inc. (NASDAQ:SSTI) from Buy to Hold on August 14, 2026.
Read moreFreedom Broker analysts upgraded Lifeway Foods, Inc. (NASDAQ:LWAY) from Hold to Buy on August 14, 2026.
Read moreB. Riley Securities reiterated its Neutral rating on WhiteHorse Finance, Inc.
Read moreJP Morgan reiterated its Overweight rating on Oculis Holding AG (NASDAQ:OCS) on August 14, 2026.
Read moreBMO Capital reiterated its Market Perform rating on Lithium Americas Corp. (NYSE:LAC) on August 14, 2026.
Read moreUBS reiterated its Neutral rating on Cogent Communications Holdings, Inc. (NASDAQ:CCOI) on August 14, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on PagerDuty, Inc. (NYSE:PD) on August 14, 2026.
Read moreCantor Fitzgerald analysts upgraded Capricor Therapeutics, Inc. (NASDAQ:CAPR) from Neutral to Overweight on August 14, 2026.
Read moreEvercore ISI Group analysts initiated coverage on Alvotech (NASDAQ:ALVO) with a rating of Outperform on August 14, 2026.
Read moreStifel reiterated its Buy rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read moreMorgan Stanley reiterated its Equal-Weight rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read morePiper Sandler reiterated its Overweight rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read moreJP Morgan reiterated its Overweight rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read moreWells Fargo reiterated its Overweight rating on Heartflow, Inc. Common Stock (NASDAQ:HTFL) on August 14, 2026.
Read more